BIOTECHNOLOGY AND LIFE SCIENCES products beginning with : A
5701 to 5750 of 9097 results Page: 
100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 [115] 116 117 118 119 120 
100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 [115] 116 117 118 119 120
Anti-IGHE (Quilizumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-IGHE (Quilizumab)-SMCC-DM1 ADC (1 supplier)
Anti-IGHE (Quilizumab)-SPDB-DM4 ADC (1 supplier)
Anti-IL-17RA Aptamer (1 supplier)
Anti-IL-6R Aptamer (1 supplier)
Anti-IL10RA aptamer (1 supplier)
Anti-IL12+IL23 (Briakinumab)-MC-MMAF ADC (1 supplier)
Anti-IL12+IL23 (Briakinumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-IL12+IL23 (Briakinumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-IL12+IL23 (Briakinumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-IL12+IL23 (Briakinumab)-SMCC-DM1 ADC (1 supplier)
Anti-IL12+IL23 (Briakinumab)-SPDB-DM4 ADC (1 supplier)
Anti-IL12+IL23 (Ustekinumab)-MC-MMAF ADC (1 supplier)
Anti-IL12+IL23 (Ustekinumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-IL12+IL23 (Ustekinumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-IL12+IL23 (Ustekinumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-IL12+IL23 (Ustekinumab)-SMCC-DM1 ADC (1 supplier)
Anti-IL12+IL23 (Ustekinumab)-SPDB-DM4 ADC (1 supplier)
Anti-IL13 (Anrukinzumab)-MC-MMAF ADC (1 supplier)
Anti-IL13 (Anrukinzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-IL13 (Anrukinzumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-IL13 (Anrukinzumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-IL13 (Anrukinzumab)-SMCC-DM1 ADC (1 supplier)
Anti-IL13 (Anrukinzumab)-SPDB-DM4 ADC (1 supplier)
Anti-IL13 (Lebrikizumab)-MC-MMAF ADC (1 supplier)
Anti-IL13 (Lebrikizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-IL13 (Lebrikizumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-IL13 (Lebrikizumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-IL13 (Lebrikizumab)-SMCC-DM1 ADC (1 supplier)
Anti-IL13 (Lebrikizumab)-SPDB-DM4 ADC (1 supplier)
Anti-IL13 (Tralokinumab)-MC-MMAF ADC (1 supplier)
Anti-IL13 (Tralokinumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-IL13 (Tralokinumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-IL13 (Tralokinumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-IL13 (Tralokinumab)-SMCC-DM1 ADC (1 supplier)
Anti-IL13 (Tralokinumab)-SPDB-DM4 ADC (1 supplier)
Anti-IL13 Neutralizing Antibody (V3S-0522-YC8055) (1 supplier)
Anti-IL13 Neutralizing Antibody (V3S-0622-YC266) (1 supplier)
Anti-IL13 Neutralizing Antibody (V3S-0622-YC4585) (1 supplier)
Anti-IL13 Neutralizing Antibody (V3S-0622-YC4587) (1 supplier)
Anti-IL13 Neutralizing Antibody (V3S-0622-YC4588) (1 supplier)
Anti-IL13RA1 (ECD domain) Neutralizing Antibody (V3S-0522-YC607) (1 supplier)
Anti-IL13RA2 Neutralizing Antibody (V3S-0622-YC1843) (1 supplier)
Anti-IL15 Neutralizing Antibody (V3S-0522-YC8277) (1 supplier)
Anti-IL15 Neutralizing Antibody (V3S-0622-YC4589) (1 supplier)
Anti-IL17A (Bimekizumab)-MC-MMAF ADC (1 supplier)
Anti-IL17A (Bimekizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-IL17A (Bimekizumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-IL17A (Bimekizumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-IL17A (Bimekizumab)-SMCC-DM1 ADC (1 supplier)
Anti-IGHE (Quilizumab)-SMCC-DM1 ADC (1 supplier)
Anti-IGHE (Quilizumab)-SPDB-DM4 ADC (1 supplier)
Anti-IL-17RA Aptamer (1 supplier)
Anti-IL-6R Aptamer (1 supplier)
Anti-IL10RA aptamer (1 supplier)
Anti-IL12+IL23 (Briakinumab)-MC-MMAF ADC (1 supplier)
Anti-IL12+IL23 (Briakinumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-IL12+IL23 (Briakinumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-IL12+IL23 (Briakinumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-IL12+IL23 (Briakinumab)-SMCC-DM1 ADC (1 supplier)
Anti-IL12+IL23 (Briakinumab)-SPDB-DM4 ADC (1 supplier)
Anti-IL12+IL23 (Ustekinumab)-MC-MMAF ADC (1 supplier)
Anti-IL12+IL23 (Ustekinumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-IL12+IL23 (Ustekinumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-IL12+IL23 (Ustekinumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-IL12+IL23 (Ustekinumab)-SMCC-DM1 ADC (1 supplier)
Anti-IL12+IL23 (Ustekinumab)-SPDB-DM4 ADC (1 supplier)
Anti-IL13 (Anrukinzumab)-MC-MMAF ADC (1 supplier)
Anti-IL13 (Anrukinzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-IL13 (Anrukinzumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-IL13 (Anrukinzumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-IL13 (Anrukinzumab)-SMCC-DM1 ADC (1 supplier)
Anti-IL13 (Anrukinzumab)-SPDB-DM4 ADC (1 supplier)
Anti-IL13 (Lebrikizumab)-MC-MMAF ADC (1 supplier)
Anti-IL13 (Lebrikizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-IL13 (Lebrikizumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-IL13 (Lebrikizumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-IL13 (Lebrikizumab)-SMCC-DM1 ADC (1 supplier)
Anti-IL13 (Lebrikizumab)-SPDB-DM4 ADC (1 supplier)
Anti-IL13 (Tralokinumab)-MC-MMAF ADC (1 supplier)
Anti-IL13 (Tralokinumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-IL13 (Tralokinumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-IL13 (Tralokinumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-IL13 (Tralokinumab)-SMCC-DM1 ADC (1 supplier)
Anti-IL13 (Tralokinumab)-SPDB-DM4 ADC (1 supplier)
Anti-IL13 Neutralizing Antibody (V3S-0522-YC8055) (1 supplier)
Anti-IL13 Neutralizing Antibody (V3S-0622-YC266) (1 supplier)
Anti-IL13 Neutralizing Antibody (V3S-0622-YC4585) (1 supplier)
Anti-IL13 Neutralizing Antibody (V3S-0622-YC4587) (1 supplier)
Anti-IL13 Neutralizing Antibody (V3S-0622-YC4588) (1 supplier)
Anti-IL13RA1 (ECD domain) Neutralizing Antibody (V3S-0522-YC607) (1 supplier)
Anti-IL13RA2 Neutralizing Antibody (V3S-0622-YC1843) (1 supplier)
Anti-IL15 Neutralizing Antibody (V3S-0522-YC8277) (1 supplier)
Anti-IL15 Neutralizing Antibody (V3S-0622-YC4589) (1 supplier)
Anti-IL17A (Bimekizumab)-MC-MMAF ADC (1 supplier)
Anti-IL17A (Bimekizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-IL17A (Bimekizumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-IL17A (Bimekizumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-IL17A (Bimekizumab)-SMCC-DM1 ADC (1 supplier)
